IntuitiveX leverages artificial intelligence across digital health, biotech, pharma, and medical devices. It navigates medical IP innovation, transporting healthcare innovations from idea to commercialization.

IntuitiveX

IntuitiveX | 2,254 followers on LinkedIn. An AI-First Medical Innovation Incubator and Consultancy with a portfolio of 3/12 FDA Breakthrough Device Companies | IntuitiveX is an AI-first medical innovation incubator and consultancy that specializes in intellectual property and providing commercialization services to grow companies no matter what stage they are in across medical devices, biotech, pharma, and digital health.

As IP &amp; commercialization experts, we discover and unlock the potential of breakthrough ideas by applying our extensive network and resources to make them possible.

President & Chief Legal Officer

Mark Han

Corporate VP and Managing Director (Microsoft Research) | Board Director (ResMed + Washington Research Foundation) | Startup and Real Estate…

Desney Tan

Managing Partner at IX Innovation LLC

Simon Robinson

CEO at Amplify Surgical

Andy Choi

Congratulations to @Neuro20 Technologies for their recognition at @ShepherdCenter in Atlanta! #Neuro20 #InnovateHealth #SuitUp2gether

Embracing the power of technology to overcome challenges. Meet Tony, a true inspiration who's not letting anything hold him back. #SuitUp With bilateral prosthetics, Tony shows us that resilience knows no bounds. We're honored to be a part of his journey with #Neuro20 as he aims to "Make Hard Better." Thank you for sharing your story, Tony. Together, we're breaking barriers and moving forward! #SuitUp2gether #Tech2MoveU

IX Innovation, a medical IP creation and monetization company and portfolio company of IntuitiveX, in partnership with ipCapital Group , is thrilled to announce the grant of a landmark patent for a voice-controlled medical copilot designed to revolutionize surgical procedures. The U.S. Patent and Trademark Office (USPTO) issued U.S. Patent 11,896,324 entitled “System for transcribing and performing analysis on patient data". This innovative technology, the brainchild of a team led by Dr. Jeffrey Roh , CEO of IntuitiveX, Dr. Justin Esterberg, an orthopedic surgery specialist, and John Cronin , Chairman and CEO of ipCapital Group, marks a new era in medical procedures that leverages AI/ML to provide patient-specific analysis, diagnosis and surgical control. This pioneering technology incorporates voice command capabilities into robotic surgical systems, offering surgeons enhanced precision and efficiency. This innovation is set to redefine surgical methodologies and patient care, marking a critical milestone in IX Innovation's commitment to revolutionizing medical technology. Under the guidance of Dr. Roh, a renowned figure in medical innovation, and Dr. Esterberg, with his profound expertise in orthopedic surgery, alongside Mr. Cronin, a pioneer in intellectual property strategy, this patent exemplifies IX Innovation's dedication to evolving medical practices through innovative solutions. The medical copilot patent embodies a new era in surgical procedures, promising significant impact on the medical industry by broadening the capabilities of robotic surgery and elevating the standards of patient treatment. IX Innovation, together with ipCapital, continues to lead the charge in healthcare innovation, developing technologies that not only improve patient outcomes but also transform medical practices. For more information, please contact: Simon Robinson – srobinson@intuitivex.com A link to preview the issued U.S. Patent 11,896,324: https://lnkd.in/gDfYjQRH

INTU

COM:INTUITIVEX

IntuitiveX